Publication Name	World Journal of Hepatology
Manuscript ID	21076
Country	India

Received	2015-06-29 18:55
Peer-Review Started	2015-07-05 19:48
To Make the First Decision	2015-07-28 10:53
Return for Revision	2015-08-09 20:23
Revised	2015-08-29 01:38
Second Decision	2015-11-12 14:02
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-11-25 15:37
Articles in Press	2015-11-25 15:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-26 09:22
Publish the Manuscript Online	2015-12-04 15:24

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Treating morbid obesity in cirrhosis: A quest of holy grail
Manuscript Source	Invited Manuscript
All Author List	Naveen Kumar and Narendra Singh Choudhary
Funding Agency and Grant Number
Corresponding Author	Dr. Narendra Singh Choudhary, Consultant, Department of Transplant Hepatology, Medanta Liver Institute, Medanta the Medicity, CH Bakhtawar Singh Road, Gurgaon 122001, Haryana, India. docnarendra@gmail.com
Key Words	Obesity; Intragastric balloon; Antiobesity drugs; Bariatric surgery; Cirrhosis
Core Tip	The rising obesity problem is also associated with increased incidence of simultaneous obesity and cirrhosis. This is a particularly difficult subset of obese patients to treat as there is difficulty in implementation of lifestyle measures, limited data on safety of anti-obesity drugs and high risk of surgery. In present review, we briefly discuss various modalities of weight reduction in obese patients and their applicability in patients with cirrhosis.
Publish Date	2015-12-04 15:24
Citation	Kumar N, Choudhary NS. Treating morbid obesity in cirrhosis: A quest of holy grail. World J Hepatol 2015; 7(28): 2819-2828
URL	http://www.wjgnet.com/1948-5182/full/v7/i28/2819.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i28.2819

Full Article (PDF)	WJH-7-2819.pdf
Full Article (Word)	WJH-7-2819.doc
Manuscript File	21076-Review.docx
Answering Reviewers	21076-Answering reviewers.pdf
Audio Core Tip	21076-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21076-Conflict-of-interest statement.pdf
Copyright License Agreement	21076-Copyright assignment.pdf
Peer-review Report	21076-Peer-review(s).pdf
Scientific Misconduct Check	21076-Scientific misconduct check.pdf
Scientific Editor Work List	21076-Scientific editor work list.pdf